Crinetics Pharmaceuticals, Inc. (CRNX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1237140,
    "name": "Crinetics Pharmaceuticals, Inc.",
    "stock_name": "Crinetics Pharmaceuticals, Inc.",
    "full_name": "Crinetics Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/crinetics-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "47.42",
    "chg": 2.41,
    "chgp": "5.35%",
    "dir": 1,
    "prev_price": "45.01",
    "mcapval": "3,309.34",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US22663K1079",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.51 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/crinetics-pharmaceuticals-inc-1237140-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Crinetics Pharmaceuticals Hits Day Low of $38.81 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/crinetics-pharmaceuticals-hits-day-low-of-3881-amid-price-pressure-3686576",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CrineticsPharma_priceRelatedfactors_3686576.png",
        "date": "2025-11-10 17:53:56",
        "description": "Crinetics Pharmaceuticals, Inc. has faced significant challenges, with a notable decline in stock performance and ongoing financial difficulties, including 25 consecutive quarters of negative results. Despite a substantial increase over the past three years, the company's recent trajectory and year-to-date performance raise concerns about its profitability and market position."
      },
      {
        "title": "Crinetics Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/crinetics-pharmaceuticals-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-stock-price-increase-3652096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/CrineticsPharma_technicaldot_3652096.png",
        "date": "2025-10-28 15:47:01",
        "description": "Crinetics Pharmaceuticals, Inc. has experienced significant stock price fluctuations, currently at $44.34. The company has shown notable volatility over the past year, with a 52-week high of $62.53 and a low of $24.10. Its recent performance has outpaced the S&P 500 in the short term, while year-to-date returns reflect underperformance."
      },
      {
        "title": "Is Crinetics Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crinetics-pharmaceuticals-inc-technically-bullish-or-bearish-3651443",
        "imagepath": "",
        "date": "2025-10-28 11:43:24",
        "description": "As of 24 October 2025, the technical trend for Crinetics Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish. The daily moving averages indicate a bullish stance. However, the monthly Bollinger Bands and KST show bearish signals, and the Dow Theory indicates a mildly bullish trend on the weekly timeframe with no trend on the monthly. \n\nIn terms of performance, the stock has underperformed the S&P 500 year-to-date and over the past year, with returns of -19.83% and -30.22%, respectively, compared to the S&P 500's 15.47% and 16.90%. However, over the longer term, the stock has significantly outperformed the benchmark with a 3-year return of 141.26% versus 78.85% for the S&P 500. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and moving averages...."
      },
      {
        "title": "Is Crinetics Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crinetics-pharmaceuticals-inc-technically-bullish-or-bearish-3647894",
        "imagepath": "",
        "date": "2025-10-27 11:54:34",
        "description": "As of 24 October 2025, the technical trend for Crinetics Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals. The daily moving averages are bullish, supporting a positive short-term outlook. However, the monthly Bollinger Bands and KST are bearish, which adds caution to the overall stance. The Dow Theory shows a mildly bullish trend on the weekly chart, while the monthly chart indicates no trend. Overall, the technical stance is mildly bullish, driven primarily by the bullish daily moving averages and weekly MACD, despite some bearish signals in longer time frames. Multi-period return data is not available for comparison with the S&P 500...."
      },
      {
        "title": "Is Crinetics Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crinetics-pharmaceuticals-inc-technically-bullish-or-bearish-3646427",
        "imagepath": "",
        "date": "2025-10-26 11:29:08",
        "description": "As of 24 October 2025, the technical trend for Crinetics Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals. The daily moving averages are bullish, supporting a positive short-term outlook. However, the monthly Bollinger Bands and KST are bearish, which adds caution to the longer-term perspective. The stock has underperformed the S&P 500 year-to-date and over the past year, with returns of -19.83% and -30.22% respectively, compared to the S&P's 15.47% and 16.90%. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and weekly MACD, but tempered by bearish signals in the monthly indicators...."
      },
      {
        "title": "Crinetics Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/crinetics-pharmaceuticals-forms-golden-cross-signaling-potential-bullish-breakout-3619685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/CrineticsPharma_goldencross_3619685.png",
        "date": "2025-10-14 15:31:09",
        "description": "Crinetics Pharmaceuticals has recently achieved a Golden Cross, indicating a potential shift in momentum. While current indicators show bullish trends, mixed signals appear in longer-term metrics. Despite a one-year decline, the company has seen a notable three-year performance increase, drawing investor interest amid industry trends."
      },
      {
        "title": "Crinetics Pharmaceuticals Hits Day High with 16.05% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/crinetics-pharmaceuticals-hits-day-high-with-1605-surge-in-stock-price-3585912",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/CrineticsPharma_priceRelatedfactors_3585912.png",
        "date": "2025-10-01 16:19:40",
        "description": "Crinetics Pharmaceuticals, Inc. has seen a notable increase in stock performance, achieving significant gains recently. Despite this short-term success, the company has struggled with negative results over the past 25 quarters and a substantial decline in operating profit over the last five years, alongside a market capitalization of USD 3,309 million."
      },
      {
        "title": "Crinetics Pharmaceuticals Opens with 14.43% Gain, Surpassing S&P 500's 0.59% Rise",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/crinetics-pharmaceuticals-opens-with-1443-gain-surpassing-sp-500s-059-rise-3579107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/CrineticsPharma_gapup_3579107.png",
        "date": "2025-09-29 14:18:31",
        "description": "Crinetics Pharmaceuticals, Inc. has experienced a significant stock surge, with notable increases over the past day and month, outpacing the S&P 500. However, the company faces ongoing financial challenges, including negative operating profit growth and consecutive quarterly losses, indicating a complex financial situation despite recent performance gains."
      },
      {
        "title": "Crinetics Pharmaceuticals Hits Day High with 27.92% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/crinetics-pharmaceuticals-hits-day-high-with-2792-surge-in-stock-price-3579100",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/CrineticsPharma_priceRelatedfactors_3579100.png",
        "date": "2025-09-29 14:13:22",
        "description": "Crinetics Pharmaceuticals, Inc. has seen notable trading activity, with a significant intraday high reached recently. The company has shown impressive short-term gains, outperforming the S&P 500, but faces longer-term challenges, including negative cash flow and a history of quarterly losses, with a market capitalization of USD 3,309 million."
      }
    ],
    "total": 16,
    "sid": "1237140",
    "stock_news_url": "https://www.marketsmojo.com/news/crinetics-pharmaceuticals-inc-1237140"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Crinetics Pharmaceuticals Hits Day Low of $38.81 Amid Price Pressure

2025-11-10 17:53:56

Crinetics Pharmaceuticals, Inc. has faced significant challenges, with a notable decline in stock performance and ongoing financial difficulties, including 25 consecutive quarters of negative results. Despite a substantial increase over the past three years, the company's recent trajectory and year-to-date performance raise concerns about its profitability and market position.

Crinetics Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Fluctuations

2025-10-28 15:47:01

Crinetics Pharmaceuticals, Inc. has experienced significant stock price fluctuations, currently at $44.34. The company has shown notable volatility over the past year, with a 52-week high of $62.53 and a low of $24.10. Its recent performance has outpaced the S&P 500 in the short term, while year-to-date returns reflect underperformance.

Is Crinetics Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-28 11:43:24

As of 24 October 2025, the technical trend for Crinetics Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish. The daily moving averages indicate a bullish stance. However, the monthly Bollinger Bands and KST show bearish signals, and the Dow Theory indicates a mildly bullish trend on the weekly timeframe with no trend on the monthly. In terms of performance, the stock has underperformed the S&P 500 year-to-date and over the past year, with returns of -19.83% and -30.22%, respectively, compared to the S&P 500's 15.47% and 16.90%. However, over the longer term, the stock has significantly outperformed the benchmark with a 3-year return of 141.26% versus 78.85% for the S&P 500. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and moving averages....

Is Crinetics Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-27 11:54:34

As of 24 October 2025, the technical trend for Crinetics Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals. The daily moving averages are bullish, supporting a positive short-term outlook. However, the monthly Bollinger Bands and KST are bearish, which adds caution to the overall stance. The Dow Theory shows a mildly bullish trend on the weekly chart, while the monthly chart indicates no trend. Overall, the technical stance is mildly bullish, driven primarily by the bullish daily moving averages and weekly MACD, despite some bearish signals in longer time frames. Multi-period return data is not available for comparison with the S&P 500....

Is Crinetics Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-26 11:29:08

As of 24 October 2025, the technical trend for Crinetics Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals. The daily moving averages are bullish, supporting a positive short-term outlook. However, the monthly Bollinger Bands and KST are bearish, which adds caution to the longer-term perspective. The stock has underperformed the S&P 500 year-to-date and over the past year, with returns of -19.83% and -30.22% respectively, compared to the S&P's 15.47% and 16.90%. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and weekly MACD, but tempered by bearish signals in the monthly indicators....

Crinetics Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout

2025-10-14 15:31:09

Crinetics Pharmaceuticals has recently achieved a Golden Cross, indicating a potential shift in momentum. While current indicators show bullish trends, mixed signals appear in longer-term metrics. Despite a one-year decline, the company has seen a notable three-year performance increase, drawing investor interest amid industry trends.

Crinetics Pharmaceuticals Hits Day High with 16.05% Surge in Stock Price

2025-10-01 16:19:40

Crinetics Pharmaceuticals, Inc. has seen a notable increase in stock performance, achieving significant gains recently. Despite this short-term success, the company has struggled with negative results over the past 25 quarters and a substantial decline in operating profit over the last five years, alongside a market capitalization of USD 3,309 million.

Crinetics Pharmaceuticals Opens with 14.43% Gain, Surpassing S&P 500's 0.59% Rise

2025-09-29 14:18:31

Crinetics Pharmaceuticals, Inc. has experienced a significant stock surge, with notable increases over the past day and month, outpacing the S&P 500. However, the company faces ongoing financial challenges, including negative operating profit growth and consecutive quarterly losses, indicating a complex financial situation despite recent performance gains.

Crinetics Pharmaceuticals Hits Day High with 27.92% Surge in Stock Price

2025-09-29 14:13:22

Crinetics Pharmaceuticals, Inc. has seen notable trading activity, with a significant intraday high reached recently. The company has shown impressive short-term gains, outperforming the S&P 500, but faces longer-term challenges, including negative cash flow and a history of quarterly losses, with a market capitalization of USD 3,309 million.

View All News